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EXPRESSED ON 9 DECEMBER 1993 
1. Terms of reference 
To re-evaluate the safety in use of propylene glycol (PG) in the light of the presently available 
toxicity data and indications of changing patterns of use. 
2. Background 
PG is currently listed in Community legislation relating to food only as a permitted diluent and carrier 
solvent for antioxidants. A proposal for a directive on food additives other than colours and 
sweeteners presently before the Council of Ministers would restrict the use of PG as a diluent and 
carrier to colours, emulsifiers, antioxidants and enzymes. 
In its 11th Series of Reports on Solvents (EUR 7421, 1981) the Scientific Committee for Food expressed 
the following opinion in relation to PG: 
"There are sufficient data available from oral toxicity studies, including long-term 
studies in rats and dogs, to establish an ADI of 0-25 mg/kg b.w. (JECFA, 1973). The 
Committee agrees with the ADI established by JECFA and considers the use of this 
substance acceptable as solvent for food. Because of the information submitted on the 
extensive use of this substance in food technology the Committee recommended that the 
intake from all sources should be reviewed in relation to the established ADI". 
At its 75th meeting, in October 1990, the Committee evaluated propylene glycol alginate, It allocated 
an ADI "not specified" for alginic acid and its sodium, potassium and calcium salts but maintained the 
ADI of 25 mg/kg b.w., expressed as PG, for the ester. The Committee also expressed the wish to re-
evaluate the ADI for PG at a future stage and reiterated the request that the intake from all sources 
of this solvent should be reviewed in relation to the ADI. 
Preliminary results of surveys undertaken in Denmark indicate a large use of PG in some food 
commodities and to an extent not fully explainable by its use as a carrier solvent. 
In addition, some recent information has become available on the toxicity of PG in cats and reviews of 
previous results suggest a need for revision of the present ADI. In relation to pet food, PG is presently 
allowed in dog food up to a maximum of 53 g/kg and for cat food up to a maximum of 75 g/kg complete 
feeding stuff. A review of the toxicity data relating to cats has prompted the Scientific Committee for 
Animal Nutrition to give the following provisional advice: 
"addition of 1,2-propanediol to feedingstuffs for cats to be reduced to 40 g/kg complete 
feeding stuff. Adequate dose-response relationships for various strains of cats and an NEL 
for the observed reduced life span of erythrocytes is to be provided. In the light of this 
information a review will be undertaken." 
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3. Discussion 
PG is rapidly absorbed from the gastro-intestinal tract of mammals, quickly distributes in the whole 
body water, and is partially rapidly excreted and partially metabolised to lactic acid, pyruvic acid 
and carbon dioxide, thus essentially contributing well-known intermediates of mammalian 
carbohydrate metabolism. The reported pharmacological or biochemical reactions only occur with 
high parenteral doses and are of little relevance to the safety assessment of PG when ingested 
through food. 
PG has a very low acute oral toxicity in laboratory animals and only very high oral doses have 
produced central nervous system depression and minimal renal and liver changes. For these reasons 
there has been a wide use of PG as a solvent carrier in pharmaceutical preparations and those 
intended for topical application. No systemic injuries to humans have been reported following dermal 
applications, the main effects being irritation of the skin in some people possibly due to dehydration 
effects. There is no evidence for PG being a primary sensitizer in man. 
Short-term studies in rats, rabbits and dogs showed no adverse effects at levels approximating 10% in 
the diet. Long-term feeding studies in rats, with 5% in the diet being the highest level tested, showed 
no adverse effects. In a 2-year feeding study in dogs the no-adverse-effect level was 2 g/kg b.w. 
Reproductive effects were noted in rats only at dietary doses which caused maternal toxicity. No 
teratogenic effects were observed in mice, rats, rabbits and hamsters. No convincing evidence for a 
genotoxic potential has been demonstrated in several in vitro and in vivo assays for different 
mutagenicity end-points but one in vivo assay at germ cell level was suggestive of a possible potential 
to induce chromosomal aberrations in spermatocytes. 
Cats appear to be uniquely sensitive to haematological effects of ingested PG, responding with a 
highly significant increase of Heinz bodies in circulating erythrocytes at PG concentrations found in 
commercially available cat food. The half-life of circulating erythrocytes was also reduced. Due to 
the failure of the feline spleen to cull Heinz body-containing erythrocytes these remain in the 
circulating blood with little haemolysis occurring. The latter is easily compensated by increased 
reticulocytosis. These adverse effects are considered minimal in healthy cats, but may cause anaemia 
under severe endogenous or exogenous oxidant stress or with concomitant inflammation or other 
processes depressing erythropoiesis. Dogs show similar haematological effects but at much higher 
doses. No haematological signs have been reported in humans receiving oral or intra-venous 
medication containing PG as vehicle. 
The present ADI of 25 mg/kg b.w. is based on the no-adverse effect level in the long-term rat studies in 
which, however, the maximum tolerated dose has not been reached. A safety factor of 100 was used to 
establish this ADI on the basis of the metabolism of PG, its total toxicity profile, and the large 
human experience with oral and parenteral pharmaceutical preparations containing PG as a vehicle. 
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4. Conclusion 
There are no new toxicological studies which would persuade the Committee to increase the present 
ADI. Moreover, the haematological findings in cats, and to a lesser degree in dogs, constitute 
additional arguments for maintaining this view. 
The uncertainty with regard to potential mutagenic effects at the germ cell level, the fact that most 
studies at the chromosomal level used limited protocols, that there is no in vitro assay for gene 
mutation in cultured mammalian cells as well as the absence of a carcinogenicity study in a second 
species led the Committee to change the established full ADI into a temporary ADI of 25 mg/kg b.w. 
To clarify the existing doubts, the Committee recommended that the results of an in vitro mouse 
lymphoma cell assay, which is known to be sensitive both to gene mutations and chromosomal effects, 
be provided. Alternatively, the results of in vitro chromosomal aberration and gene mutation assays 
in cultured mammalian cells, preferably human peripheral lymphocytes, carried out using the most 
recent recommended international protocols, would be acceptable. 
The Committee re-iterates its wish that the intake of PG from all sources in the Community be 
reviewed in order to enable maximum limits to be set for its uses in food technology should it become 
apparent that the intake is exceeding the ADI on a regular basis. 
Reports of the Scientific Committee for Food (Thirty-fifth series) OPINION ON ALTERNATIVELY REFINED CARRAGEEN AN PRODUCED FROM EUCHEUMA 
COTTOMI AND EUCHEUMA SPINOSUM 
EXPRESSED ON 25 FEBRUARY 1994 
1. Terms of reference 
To advise on the safety in use of alternatively refined carrageenan produced from Eucheuma cottonii 
and Eucheuma spinosiini. 
2. Background 
In October 1991 the Commission received an application from the Seaweed Industry Association and 
the Government of the Philippines (Seaweed Industry Association of the Philippines, 1991) to assess 
the specification and safety-to-health of carrageenan manufactured by an alternative process 
(alternatively refined carrageenan-ARC) to that used for the production of conventionally refined 
carrageenan (CRC). 
ARC is claimed to be prepared only from Eucheuma cottonii and Eucheuma spinosum, the commonest 
sources of commercial carrageenan. The process of manufacture consists essentially of the treatment of 
washed seaweed with strong alkali to coagulate carrageenan inside the plant cells without 
extracting it. After some clean-up steps the coagulated carrageenan together with cellulosic debris 
from the cell wall and other cell constituents is converted into a powdery end product. 
In contrast, the CRC is extracted from the seaweed cells with mild alkali. The extracted carrageenan 
is then cleaned up and precipitated with alcohol, the precipitated material being eventually 
converted into a powdery end product consisting essentially of carrageenan and mineral salt. It 
therefore does not contain any cell wall debris and needs a separate purity specification to distinguish 
it from ARC. 
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The table below compares the major parameters of the specifications for purity of CRC and ARC. 
Parameter CRC ARC 
Carrageenan polysaccharides 
Total ash (dry basis) 
Acid insoluble matter (a.i.m.) less than 
Crude fibre 
Viscosity (filtered) 
Viscosity (as is) 
Heavy metals less than 
74% 
36.3% 
0.1% 
0.2% 
12cps 
15cps 
1.4 mg/kg 
73.3% 
20.9% 
11.2% 
6.5% 
105 cps 
215 cps 
3.9 mg/kg 
The method of production of ARC is sufficiently different from that used for the production of CRC, so 
that a clear distinction can be made in the specifications for purity of the two products. The main 
polysaccharide is kappa-carrageenan in both cases, there being little difference in the respective 
concentrations. The presence of 10-12% acid insoluble matter (a.i.m.) in ARC constitutes the major 
difference from CRC. Carrageenan has been a permitted food additive in the EU, appearing in the 
Directive 74/329/EEC. 
Because of the incompleteness of the data in the original submission of ARC and the unavoidable 
delay in obtaining the additional information required by the Committee to complete the assessment 
of the safety of ARC, some considerable time has elapsed before a final evaluation could be made. 
The recent additional data now provided relate to the chemical nature of the a.i.m., the molecular 
weight distribution of the carrageenan in ARC and the microbiological status of the ARC. The results 
of a 90-day feeding study in rats, of several in vitro and in vivo genotoxicity tests, and of cytotoxicity 
tests using bone marrow mononuclear cell and hepatocyte cultures have also been supplied. 
3. Evaluation 
The toxicology of carrageenan (CRC) has been evaluated previously by the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA), last in 1984, and is summarized in the relevant JECFA 
monograph (IPCS 1984). The SCF reviewed carrageenan in 1978 (Scientific Committee for Food, 1978) 
and at that time agreed with the then existing ADI for man of 0-75 mg/kg bw previously established 
by JECFA. The Committee re-evaluated carrageenan (CRC) in 1992 when it confirmed the ADI of 0-75 
mg/kg bw (Scientific Committee for Food, in press). 
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The analytical data on ARC show that the molecular weight distribution of the kappa-carrageenan 
component was similar for ARC and CRC and that the low molecular weight fractions are also 
similar. The microbiological data for ARC show the absence of pathogenic organisms in the large 
number of samples examined. X-ray diffraction powder analysis suggests that the a.i.m. is probably 
similar to amorphous cellulose. This is apparently confirmed by infrared absorbance measurements on 
kappa-carrageenan films from ARC. These measurements also detected the presence of calcium 
carbonate as a component of a.i.m. No bands characteristic of a long-chain carboxylic acid, originally 
suspected to be present, could be found in films of washed and unwashed ARC from 2 sources nor in a 
film of a commercial CRC. 
The subchronic rat study on ARC shows no obvious adverse effects, thus excluding the presence of toxic 
compounds. The NOEL in this study is 5% ARC in the diet, the highest level tested. The in vitro 
genotoxicity tests using bacterial test systems, including an additional Salmonella reverse mutation 
test, are negative, thereby excluding the presence of genotoxic contaminants. The highest level of 
a.i.m. in the samples examined is 112 μg/plate. The two available in vivo genotoxicity tests confirm 
the absence of any genotoxic or clastogenic activity. The doses of ARC examined are estimated to have 
been equivalent to an exposure of approximately 8 mg a.i.m. per animal. The interpretation of the 
results of the submitted cytotoxicity tests remain unclear. 
4. Conclusion 
The details supplied on the specification, the chemical analysis and the microbiological status of 
ARC, the identification of the nature of the a.i.m. as amorphous cellulose and the absence of other 
toxic contaminants enable the Committee to consider ARC to be an acceptable carrageenan 
preparation. The absence of toxic effects in the 90-day study and the evidence for the absence of 
genotoxicity additionally support this opinion of the Committee and its conclusion that further 
toxicological testing is not needed. 
Although JECFA eventually established an ADI "not specified" for CRC, the Committee wishes to 
maintain the original group ADI for all carrageenans (CRC and ARC) of 0-75 mg/kg bw for man 
because of some remaining uncertainty over the general immunoreactive potential of the various 
carrageenans now in use as food additives. 
The Committee also concluded that separated specifications of purity should be developed for ARC 
and CRC, each specification being formulated to reflect the respective method of production. It also 
noted information indicating that traces of ethylene oxide had been found in batches of ARC 
circulating in commerce in North America and Europe. It affirmed that the treatment with ethylene 
oxide of ARC intended for food use is not acceptable. The Committee advised the Commission that, 
should it not prove to be the case that the existing law prohibits the use of ethylene oxide on 
carrageenan products, the specifications for purity should be formulated in such a way as to preclude 
this use whilst at the same time requiring the carrageenan product to meet adequate microbiological 
criteria. 
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Reports of the Scientific Committee for Food (Thirty-fifth series) OPINION ON P-HYDROXYBENZOIC ACID ALKYL ESTERS AND THEIR SODIUM SALTS 
EXPRESSED ON 25 FEBRUARY 1994 
1. Terms of reference 
To advise on the safety in use of p-hydroxybenzoic acid alkyl esters and their sodium salts as food 
additives. 
2. Introduction 
p-Hydroxybenzoic acid alkyl esters and their sodium salts (parabens, PBs) have been extensively 
used as preservatives in food over many years. In 1974 the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) evaluated several parabens and established an ADI of 0-10 mg/kg bw, as the sum 
of ethyl, methyl and propyl p-hydroxybenzoic acid and their sodium salts. JECFA was unable to 
establish an ADI for the butyl ester of p-hydroxybenzoic acid. The Scientific Committee for Food 
(SCF) has not previously established an ADI for any of the parabens. However, the SCF did consider 
one of the parabens, sodium methyl p-hydroxybenzoate, in 1975 and confirmed its agreement with the 
JECFA evaluation. Accordingly, sodium methyl p-hydroxybenzoate was added to the EC list of 
permitted food preservatives which already included methyl p-hydroxybenzoic acid and ethyl p-
hydroxybenzoic acid and its sodium salt. 
3. Summary of metabolism and toxicity data 
Many of the pharmacokinetic observations and toxicological studies on the parabens were carried out 
some years ago and would not fulfil present day criteria for conduct of studies. However, considering 
the parabens as whole, there is a considerable range of studies available and the Committee regards 
most of them as helpful for safety evaluation purposes. 
Absorption, metabolism and excretion has been studied in rats, rabbits, dogs and humans. The methyl, 
ethyl and propyl esters of p-hydroxybenzoic acid (Me-PB, Et-PB and Pr-PB) are well absorbed and 
the ester linkage is readily hydrolysed, as indicated by high plasma levels and early urinary 
excretion of free p-hydroxybenzoic acid, p-hydroxyhippuric acid and other metabolites such as ester 
glucuronides and ether sulphates. Urinary excretion of unchanged esters of p-hydroxybenzoic acid is 
very low, usually less than 1% of the administered dose. Limited in vitro data on the butyl ester (Bu-
PB) suggest it may follow a different metabolic pathway. Studies with prolonged dosing in dogs show 
no evidence of accumulation of either parent compounds or metabolites in the tissues. 
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Acute toxicity is only seen at high doses. All the parabens produce similar symptoms with rapid onset 
of ataxia, paralysis and central nervous system depression, resembling anaesthesia, suggesting their 
toxicity is related mainly to the free acid. With non-fatal doses recovery is prompt. 
Subrhronic toxicity studies on Me-PB, Et-PB and Bu-PB and chronic toxicity studies on Me-PB, Et-PB 
and Pr-PB have been conducted in rats. The no-effect level for all four parabens was 2% in the diet, 
equivalent to 0.9-1.2 g/kg bw/day. Effects occurring at a much higher dietary inclusion level of 8% 
were decreased weight gain (Me-PB and Pr-PB) accompanied by depression and death (Et-PB and Bu-
PB). Doses intermediate to 2% and 8% were not tested. Me-PB and Pr-PB have also been tested at 500 
and 1000 mg/kg bw/day given for approximately one year in the dog with a no-effect level of 1000 
mg/kg bw/day for both esters. Bu-PB has been tested in the mouse at levels up to 10% in the diet for 6 
weeks. The no-effect level in the mouse was 0.6% (equivalent to around 0.9 g/kg bw/day). 
Several in vitro mutagenicity studies covering both point mutations and chromosome aberrations, and 
an in vivo host mediated assay and dominant lethal assay provided no evidence of genotoxicity of 
Me-PB. Pr-PB and Bu-PB were not mutagenic in vitro. No mutagenicity data are available for Et-PB. 
The only long-term study specifically designed to address carcinogenicity was conducted on IHi-l'B in 
mice, given up to 0.6% in the diet for two years. It reported no significant difference in tumour rates 
between treated and control animals but was inadequate for assessment due to early deaths in treated 
and control groups and relatively high incidence of some tumours in the control group. 
Reproduction and teratogenicity studies in the rat using Et-PB at levels up to 10% in the diet found no 
adverse effects on reproductive performance but the findings with respect to fetal anomalies were 
equivocal, the reported anomalies showing no clear dose-response relationship. There are no other 
reproduction studies available for the parabens. 
A number of special studies on cell proliferation in the forestomach and glandular stomach of rats 
have been carried out using finely ground powdered parabens, fed for 9 days at up to 4% in the diet. 
Me-PB was without activity, Et-PB showed minimal activity, whilst Pr-PB and Bu-PB induced cell 
proliferation in the pre-fundic region of the forestomach. The potency depended on the alkyl chain 
length; 4% Pr-PB and Bu-PB had activities equivalent to 0.5% and 2% dietary ΒΗΛ respectively. 
4. Conclusions and recommendations 
The data available give adequate reassurance that use of the methyl, ethyl and propyl esters of p-
hydroxybenzoic acid and their sodium salts as food preservatives is temporarily acceptable. 
However, the toxicological information available shows some inadequacies and uncertainties and 
further studies along the following lines are needed: 
Since cell proliferation effects in the forestomach similar to those produced by BHA 
have been observed when certain alkyl esters of p-hydroxybenzoic acid were given in 
the diet in the form of a ground powder, a cell proliferation study in the rat on the 
propyl ester of p-hydroxybenzoic acid given as a solution should be carried out. 
In view of the equivocal findings in the existing oral teratogenicity study, a new oral 
teratogenicity study in the rat using either free p-hydroxybenzoic acid or its methyl, 
ethyl or propyl ester. 
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An overall no-effect level of 1000 mg/kg bw can be taken from the toxicity studies. The Committee 
considers that a 100-fold safety factor is appropriate, giving a temporary ADI of 0-10 mg/kg bw, as 
the sum of methyl, ethyl and propyl p-hydroxybenzoic acid and their sodium salts. The Committee 
was not required to establish an ADI for the butyl ester of p-hydroxybenzoic acid since it is not used as 
a food additive. The t-ADI will be reviewed in 3 years time in the light of any new toxicological 
studies, along the lines suggested above, together with information on consumer intakes of parabens, 
which we understand will then be available. 
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EXPRESSED ON 25 FEBRUARY 1994 
1. Introduction 
The Commission has responsibility for drawing up and agreeing with Member States specifications for 
additives which are permitted for use in the EU. The Commission has asked the Scientific 
Committee for Food (SCF) if there are any comments it wishes to make about the setting of 
specifications in general, or on the draft specifications recently prepared for colours and sweeteners. 
The SCF offers the following general advice on toxicological aspects of specifications and a few 
comments on the draft specifications for colours and sweeteners but the Committee has not examined 
each individual draft specification in detail. Additional expertise to that of the SCF is required for 
the detailed examination of individual specifications. Thus the absence of comments on particular 
substances should not be taken as endorsement of the draft specifications by the Committee and the 
SCF urges the Commission to seek such advice from appropriate specialists in the Member States. 
Should any new questions arise from such consultations which have health implications, then the 
Committee would be happy to advise the Commission further. 
2. Value of specifications 
The SCF has stressed the importance of specifications in safety evaluation in an earlier report
1. We 
reiterate the views expressed then, which still hold good today, that the material subject to 
toxicological testing should correspond to the food additive to be used in practice by the food industry. 
To achieve this, draft specifications are needed at an early stage. Tests carried out on samples for 
which there are inadequate specifications may later be found to be valueless and tests carried out 
unidentified material are of no value. Specifications are therefore an essential prerequisite for a 
sound evaluation of the safety in use of any additive; they ensure that the batches of material used in 
the toxicity and other safety tests on a particular additive are similar in composition and, whilst 
they may vary to a small extent within acceptable limits, they do not differ in any way that is 
biologically significant from the product which is eventually marketed. Any differences in the 
proportion of the major component which performs the technological function in the food or in the 
nature or amounts of any impurities present in the final product may alter the outcome of safety tests. 
For Committees such as the SCF which evaluate the safety aspects of new and existing additives, 
draft specifications should be available at the time of the evaluation. Draft specifications may also 
need to be amended in the light of the results of toxicity tests. 
Similar views have been expressed by the Joint FAO/WHO Expert Committee on Food Additives 
(JECFA) some years ago in its Eighth and Tenth Reports
2-
3 and elaborated more recently in "Principles 
for the Safety Assessment of Food Additives and Contaminants in Food". JECFA has emphasised the 
need to establish internationally agreed specifications for the identity and purity of food additives. 
The SCF endorses this view and urges the Commission, in drawing up EU specifications, to base them 
where possible on existing Member State or FAO/WHO agreed Codex specifications, provided these 
are considered satisfactory by current day standards. 
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As JECFA noted in its early reports
2·
3, agreed specifications are an essential aid in consumer 
protection, ensuring that any additives used are of known composition and puritv. They assist in the 
regulatory control and identification of additives and ensure that what is marketed does not differ 
significantly from the grade or quality of the substances that has been evaluated for its safety in use. 
They are of value to industry in ensuring that products of an agreed standard are traded between 
chemical manufacturers of the additives and those utilising them in processed foods. 
3. Information which should be included in specifications 
Specifications should include information to enable the additive to be properly identified and, where 
appropriate, should include identification tests. They should include both general purity criteria and 
specific purity criteria decided on a case-by-case basis. In case-by-case considerations any opinions 
already expressed by the SCF or JECFA concerning particular toxicological problems with known 
impurities should be taken into account by limiting the level of the impurities to that which is 
considered safe. 
As mentioned in the Tenth Report of the SCF
1, consideration of a substance's chemical structure and 
the route by which it has been synthesised will enable a search to be made for specific potential 
impurities whose presence might otherwise have escaped detection. It is important to scrutinise 
carefully not only the source of the raw materials but also the method(s) of production for persisting 
intermediates or impurities. Consideration should also be given to degradation products which may 
arise during formulation or storage. 
For some additives, methods of production may vary or new methods of production may be proposed 
for additives already on the market. For example, new methods involving biotechnology are being 
used now or will be increasingly in the future. This is particularly true, for example, for enzyme 
preparations, including preparations derived from genetically modified organisms. In cases where 
chemical or biotechnological methods of production for a particular additive vary, it may be 
necessary to evaluate separately products made by different production processes. It may also be 
necessary in some instances to have separate specifications for such products even though the major 
component performing the technological function is the same. 
4. Food additives derived from natural sources 
Additives derived from natural sources may contain only relatively small proportions of the active 
principles. In the SCF safety evaluations of natural source additives, for which there is little 
specific toxicity information, the Committee has stressed that they should be derived from edible 
parts of plants normally used for food, extracted by physical processes, and that their use as 
additives should not lead to intakes which are significantly increased compared with intakes from 
natural food sources generally. These principles need to be taken into account when drawing up 
specifications. Additives from natural but non-food sources, or from food sources used in parts of the 
world other than Europe, need to be considered on a case by case basis, both from the point of view of 
their toxicity and the specification. For food additives derived from natural sources, there may be a 
need to include limits for microbial contaminants and inherent natural toxicants. 
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5. Heavy metals 
Limits for heavy metals are useful in ensuring that avoidable sources of toxic metals, especially 
arsenic, lead, mercury and cadmium, do not contribute unnecessarily to intakes of metals from the diet. 
We wish to see such individual limits continue to be included in specifications where there is a 
possibility of heavy metal contamination. Existing specifications for many additives include limits 
for the content of arsenic and lead and, less commonly, cadmium and mercury. These limits may vary 
depending on the quantities of particular additives which need to be added to foods to achieve their 
technological function. For example, the limits may need to be lower for additives used in larger 
quantities in individual foods (e.g. bulk sweeteners, chewing gum bases, thickeners, stabilisers and 
emulsifiers), than for additives present in small amounts. The Committee recommends that limits for 
individual metals should be revised, if necessary, using the principle that the higher the maximum 
permitted level of addition of the additive to food, the lower the heavy metal limit needs to be. 
However, we do not consider it necessary to strive to reduce limits to the lowest achievable limit of 
detection since the high dilution of additives in food is such that the overall contribution of 
additives to metal intakes is generally negligible compared with other sources. 
Many existing specifications also include an overall limit for total heavy metals, expressed as lead. 
It has been brought to the Committee's attention that there may be some confusion about what the 
term "total heavy metals" includes and that the "catch-all" test currently recommended in JECFA 
specifications
5 (all metals giving a colour with hydrogen sulphide) is widely regarded as 
unsatisfactory and generally is no longer used. In discussing this problem, the Commission may wish 
to note that the Committee considers that since heavy metals are not known to be additive or 
synergistic in their actions, there is no need on toxicological grounds for an overall limit on heavy 
metals provided there is control of the individual toxic heavy metals, as discussed above. Thus, the 
currently recommended method, which expresses total heavy metals as lead, has neither an 
analytical not a health basis. 
Further specific comments about heavy metals in colours and sweeteners will be found below in the 
relevant paragraphs on the draft specifications for these categories of additives. 
6. Solvent residues 
SCF opinions on a number of individual solvents are available and these should be borne in mind when 
setting purity criteria for individual and overall solvent residues in additive preparations, but taking 
account of the likely dilution of any solvent residues when the additive is incorporated into foods. 
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Comments on draft specifications for colours 
1. General 
We note that some of the specifications deviate from Codex ones. Such changes may be appropriate 
but we recommend that the draft EU specifications be compared to the existing Codex ones to ensure 
that any differences are necessary and that the changes are logical and consistent. 
A number of unsulphonated primary aromatic amines are known to be carcinogenic in animals and a 
few are proven human carcinogens. Limiting the amount of unsulphonated primary aromatic amines in 
any azo colour to not more than 0.01% (calculated as aniline) is recommended. Aromatic amines 
sulphonated on all aromatic or conjugated ring structures are considered of low risk and do not 
normally need to be controlled by limits. Sulphonated aromatic amines other than the principal 
coloured components should be limited to not more than 0.5% of the total. 
Limits for heavy metals in colours (and perhaps other categories of additive) need some 
rationalisation. For example, not all colours are likely to be contaminated with mercury yet all have 
limits for mercury. Conversely, none of the draft specifications for colours have any limits for 
cadmium. Sources and methods of production need to be examined for each individual colour to see 
whether limits for mercury and cadmium are needed. A re-examination of the mercury limits for 
Caramel is particularly needed; whilst the limits for arsenic and lead in Caramel are lower than for 
other colours, the limit for mercury in Caramel is twice that for other colours, yet this colour is often 
added to food in much higher quantities than are other colours (see also general comments relevant to 
quantities used under "Heavy metals" above). 
2. Colours derived from natural sources 
We note that, in a number of cases, the draft specifications for natural source colours do not make it 
clear which food sources may be used or include sources which are not normally consumed by man. 
These should be reviewed in the light of the general comments made under "Food additives derived 
from natural sources" above. 
3. Ammonia caramel 
The context of 2-acetyl-4-tetrahydroxybutylimidazole (THI) in Ammonia caramel should not exceed 
10 mg/kg (SCF opinion, in press). 
4. Vegetable carbon 
Polycylic aromatic hydrocarbons should not be detectable in Vegetable carbon using an agreed 
sensitive method. 
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Comments on draft specifications for sweeteners 
1. General 
We note that some of the specifications deviate from Codex ones. Such changes may be appropriate 
but we recommend that the draft EU specifications be compared to the existing Codex ones to ensure 
that any differences are necessary and that the changes are logical and consistent. 
Limits for heavy metals in sweeteners need some rationalisation. None of the draft specifications for 
sweeteners have limits for mercury or cadmium. Some do not have limits for lead (Cyclamic acid and 
Saccharin and its salts), whilst limits for lead in others vary between 1, 3 and 10 mg/kg. Depending 
on sources and methods of production specific limits may not be necessary in some cases, but this should 
be checked. Similarly, there may be acceptable reasons for varying lead limits (e.g. related to the 
maximum amount of the additive permitted in foods) but this too should be checked and a consistent 
limit applied wherever possible. 
2. Aspartame 
The SCF has commented on the breakdown product of aspartame, diketopiperazine (5 benzyl-3, 6-
dioxo-2-piperazineacetic acid), and set an ADI of 0 - 7.5 mg/kg bw
6. The content of diketopiperazine 
in the product aspartame as supplied should not exceed 1.5%. 
3. Cyclamic acid and its salts 
Whilst the majority of the toxic substance cyclohexylamine, derived from cyclamic acid, is generated 
from metabolic conversion in vivo atter ingestion, there is a need to limit the content of the 
cyclohexylamine in cyclamic acid and its sodium and calcium salts as manufactured to not more than 
25 mg/kg, and to limit the content of dicyclohexylamine to not more than 2 mg/kg. This should ensure 
that the exposure to cyclohexylamine from that ingested and that which may be formed in vivo is 
within the temporary ADI of 0 - 11 mg/kg bw, expressed as cyclamic acid, which is based on the 
toxicity of cyclohexylamine
6
,
 7. 
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EXPRESSED ON 25 FEBRUARY 1994 
1. Terms of reference 
To advise on the safety in use of sorbic acid and its salts as preservatives for foodstuffs. 
2. Background 
These compounds have not been previously evaluated by the Scientific Committee for Food although 
they are already included in the Directive 64/54/EEC. Sorbic acid and its calcium, potassium and 
sodium salts have been evaluated, however, by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) at several meetings since 1961 and sodium sorbate was specifically reevaluated in 
1985. Most of the toxicological data, on which the present evaluation is based, have been previously 
summarized in a monograph published by WHO in 1974. Additional data were culled from a 
literature search carried out by the National Food Agency of Denmark. These data included new 
investigations on biochemical aspects, a long-term chronic toxicity/carcinogenicity study on sorbic 
acid in rats, 2-year studies in mice and rats with potassium sorbate, teratogenicity studies in mice and 
rats with potassium sorbate, a large number of in vitro and in vivo genotoxicity studies with sorbic 
acid, potassium sorbate and sodium sorbate, special studies on the reactions of sorbates with nitrite, 
and six further studies in humans with particular emphasis on the allergenicity of sorbates. 
3. Evaluation 
Sorbic acid is readily metabolised like other short-chain fatty acids. Both man and the rat appear to 
utilise identical metabolic mechanisms for the oxidation of sorbates. Under normal conditions there is 
almost complete oxidation of sorbic acid to carbon dioxide and water. 
Long-term carcinogenicity studies with sorbic acid up to 10% in the animal feed have been conducted 
in mice and rats without showing any carcinogenic effects. The rather high and widely spaced 
selected dosages used in the newer studies only permit the establishment of 1,5% in the rat and 1% in 
the mouse as approximate NOELs, while the earlier studies with lower and more closely spaced 
dosages showed the more accurately determined NOEL for potassium sorbate and sorbic acid to be 5% 
in both species. In the newer mouse study a statistically significant increase in liver weight was found 
in females at all dose levels tested but this was not accompanied by histopathological changes and 
therefore not considered to be treatment-related 
The only study reporting a carcinogenic affect on the liver of mice used a diet containing 15% sorbic 
acid. Only a summary abstract of this study is available for evaluation and it does not give enough 
details to interpret the reported findings of the study. The number of animals per group was too small 
by modern standards, only one dose level appears to have been tested and no information is given on 
the historical incidence of liver tumours in the mouse strain used. In the light of the results of all the 
other long-term studies it is reasonable to set aside these results. 
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Sorbic acid and potassium sorbate complying with the appropriate specifications do not cause tumours 
when administered orally or subcutaneously. Long-term studies with sorbic acid containing also 
parasorbic acid showed no evidence of any carcinogenic potential when administered orally to mice 
and rats. 
Experimental studies to elucidate the probable mechanism by which sorbic acid may be involved in 
the induction of hepatomas, which had been reported in studies on mice, have indicated that high 
doses (15%) of sorbic acid in the diet may reduce the levels of lipid peroxides and glutathione in the 
liver and induce hepatic peroxisomal enzyme activities. However, final explanations cannot yet be 
based on these studies. 
Sorbic acid has been tested for genotoxic activity in vitro and in vivo in various test systems. Most of 
the in vitro results have been negative. Some in vivo tests have yielded positive results, but it should 
be noted that in these experiments the control values were unusually low. 
Sorbic acid has caused hypersensitivity reactions, particularly contact urticaria, in certain 
population subgroups. 
No toxicological studies have been carried out with calcium sorbate. 
Long-term carcinogenicity studies with potassium sorbate have been conducted in mice and rats with 
doses up to 5% in the diet. However only summary interim reports are available for scrutiny. 
Potassium sorbate inclusion in the diet up to the dose level of 5% caused no carcinogenic effects in rats. 
The final data of the mouse study have not been supplied. 
Potassium sorbate has been tested for genotoxic activity in vitro and in vivo in various test systems. 
The in vitro results have been almost exclusively negative, and all the in vivo tests gave negative 
results. No teratogenic effects were noted after dosing mice with up to 460 mg/kg b.w. and rats with up 
to 340 mg/kg b.w. 
Potassium sorbate has caused hypersensitivity reactions, particularly contact urticaria, in certain 
population subgroups. 
Sodium sorbate has been tested for genotoxic activity in various in vitro and in vivo systems, both as 
freshly prepared and as stored solutions. These data indicate, that sodium sorbate is genotoxic in some 
in vitro tests and, after storage, in some in vivo tests, although the potency appears to be weak. The 
mechanism of the genotoxicity of sodium sorbate is unclear but is likely to be related to breakdown 
products formed in stored aqueous solutions. This instability does not occur with potassium sorbate or 
calcium sorbate solutions, which are the only salts with established technological use. These findings 
with sodium sorbate can therefore be set aside in the overall safety assessment of the other sorbates 
and sorbic acid. 
In 1985 the Joint FAO/WHO Expert Committee on Food Additives (JECFA) stated, that the use of the 
sodium salt instead of the calcium and potassium salts did not introduce any new toxicological 
problems, and extended the group ADI for sorbic acid and its salts to include also the sodium salt. 
However, the ADI of sorbic acid and its salts already covered the sodium salt according to the 1974 
JECFA report. It is therefore not completely clear why sodium sorbate was on the agenda of the 1985 
JECFA meeting as no additional toxicological report or specification was prepared. 
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The use of sodium sorbate appears to be very limited, and for that reason it is not included in the 
present proposal for a Community positive list of food additives nor in the title of this report. It is 
also reported not to be used any longer in Japan and it is proposed to remove it from the list of GRAS 
substances in the USA because of lack of use data. 
Overall, the lack of evidence of carcinogenicity, demonstrated in several adequate studies in 2 
species, allows the setting aside of the occasional positive result in the genotoxicity studies on 
sorbates except in the case of sodium sorbate. The latter has not been tested for carcinogenicity in any 
laboratory animal species. 
The safety in use of the combination of sorbates and nitrites has been questioned. The results of studies 
on the formation of potentially mutagenic or DNA-damaging reaction products, when sorbic acid or 
potassium sorbate are present together with nitrite, are to some extent conflicting and not convincing. 
In some of the studies with positive results, even low concentrations of nitrite alone have given rise to 
positive results. Experimental data have shown that under normal conditions of use no hazard to 
human health arises. 
4. Conclusion 
In 1973 JECFA established an acceptable daily intake (ADI) for man of 0-25 mg/kg b.w. as the sum of 
sorbic acid and its calcium, potassium and sodium salt expressed as sorbic acid. This estimate was 
based on the then available data, particularly the NOEL of 2500 mg/kg b.w./day in the long-term 
study in rats, and using a safety factor of 100. The more recent long-term study in rats, using however 
only the two dose levels 750 mg/kg b.w. and 5000 mg/kg b.w., showed that at 5000 mg/kg b.w./day 
changes in the relative weights of some organs occurred. In this study the dose level of 750 mg/kg b.w. 
would thus be the apparent NOEL. 
In the more recent long-term study in mice changes in organ weights were noted at the two highest 
dose levels of 7000 and 14000 mg/kg b.w. but none at the dose level of 1400 mg/kg b.w. The apparent 
NOEL in this study was therefore 1400 mg/kg b.w. 
Neither of these studies unfortunately included the intermediate dose level of 2500 mg/kg b.w. 
Taking into account the dose levels used in the studies evaluated by JECFA and those used in the more 
recent studies, there is no reason to alter the conclusion of the 1974 JECFA assessment, that 2500 mg/kg 
b.w./day is the best approximation to the NOEL for both mice and rats. 
Level causing no toxicological effect: Rat: 50000 ppm (5%) in the diet, equivalent to 
2500 mg/kg b.w./day 
Estimate of acceptable daily intake for man of 
sorbic acid and its calcium and potassium salts: 0-25 (*) mg/kg b.w. 
(*) group ADI expressed as sorbic acid 
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PRESERVATIVES 
EXPRESSED ON 25 FEBRUARY 1994 
1. Background 
Sulphur dioxide (E220) and various salts of sulphur (IV) oxoanions have been widely used as food 
preservatives for many years. These compounds (listed below) are commonly referred to as the 
"sulphiting agents". 
Sulphur dioxide E220 
Sodium sulphite E221 
Sodium sulphite E222 
Sodium metabisulphite E223 
Potassium metabisulphite E224 
Calcium sulphite E226 
Calcium bisulphite E227 
The SCF reviewed the toxicology of these compounds in 1981
1. The Committee then noted that there 
was a large endogenous metabolic turnover of sulphite (ca 20-40 fold the estimated dietary intake) 
and considered that it was not necessary to set an ADI at that point in time. The SCF concluded that 
for the great majority of people no hazard to health would arise from the use of sulphiting agents to 
preserve food. Since that time, there have been a number of publications which have reported 
bronchoconstriction and bronchospasm in asthmatics challenged with acidified drinks containing 
sulphite
2. It is therefore timely to further review these chemicals. 
2. Animal toxicology 
The Committee noted that there are extensive toxicological data available in animals which 
indicate that sulphiting agents have little or no systemic toxicity
3. These results are not surprising in 
view of the rapid metabolism to sulphate and elimination of these compounds in laboratory animals. 
Sulphiting agents are not carcinogenic, mutagenic or reproductive toxicants in animals. Furthermore, 
no evidence of any systemic effects attributable to sulphites has been reported in short term studies in 
rats with an induced deficiency in sulphite metabolism
4. 
The only treatment-related effects in animals attributable to sulphiting agents are localised changes 
in the stomach, of dose-related severity, which have been noted in several species including, in early 
studies, dogs, rabbits, rats, mice, guinea pigs and cattle
7·
 8. It is possible that in the early studies some 
of these gastric changes and related toxic effects may have been attributable to thiamine deficiency 
since sulphites destroy thiamine in the diet. However, similar though less marked changes have also 
been observed in more recent studies in pigs and rats in which thiamine deficiency was prevented by 
addition of a thiamine supplement to the diet
5"
10. They included inflammatory changes and 
hyperplasia in the stomach. At very high doses, decreases in growth rates and food consumption were 
also seen in pigs, probably due to unpalatability of the diet, and anaemia secondary to severe 
haemorrhage from stomach erosions was seen in rats. 
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An important consideration regarding the early tissue changes seen in the stomach in animals at lower 
doses is whether they are caused by repeated direct exposure of the stomach to sulphites, or whether 
they may be a specific but secondary change in the stomach which perhaps occurs after systemic 
absorption of sulphites. The gastric effects have been studied in some detail in rats and pigs and there 
is some evidence of a slight difference in the type of response seen in the rat and the pig
5'
11
1 In tin' rat. 
hyperkeratosis, acanthosis ulceration and intraepithelial microabscesses were seen m the 
forestomach. In the glandular stomach, inflammatory changes, necrotic cells and haemorrhagic 
erosions were observed, together with an unusual hyperplasia of the fundic glands in a small number 
of animals. The hyperplasia was limited to the chief (pepsin-secreting) cells at the base of the 
glands, an effect which is not seen with other known gastric irritants in rodents. In the pig, 
hyperkeratosis and hyperplasia of the epithelium were observed in the pars oesophagea and 
hyperplasia of the mucosal glands and surface epithelium were observed in the cardiac and pyloric 
regions of the stomach. Thus there are qualitative differences in the types of hyperplasia seen in rats 
and pigs exposed to sulphiting agents. 
The No-Observed-Effect-Level (NOEL) for gastric irritation in long-term feeding studies in both rats 
and pigs was 70 mg/kg bw/day (expressed as sulphur dioxide equivalents)
5'
6. Alter high dose 
treatments the effects on gastric pathology were reversible
6. Lesions were no more numerous or 
pronounced in long-term than in short-term experiments, there was no evidence of stomach tumours in 
long-term studies on rodents or pigs, and some of the regressive changes (erosions and necrosis) seen in 
short-term experiments were not observed in long-term studies- ""'. No evidence of any systemic etlects 
was seen in either the rat or pig at doses of approximately 8 times the NOEL, the highest doses 
tested. 
3. Human toxicology 
Gastric reactions are also known to occur in man; with very high doses of sulphites, abdominal pains 
and vomiting have been observed in human volunteers
8- ". The possible gastric effects of lower doses 
of sulphite have not been studied. 
Occasional severe asthmatic reactions, including deaths, have been recorded following the use ol 
sulphiting agents in proprietary salad fresheners on vegetables
2-
 n- ''. Salad fresheners were popular 
in the USA for some time, but have not to our knowledge been used in Europe. There is one published 
case report of an asthmatic reaction following consumption of dried apricots-. Challenge studies 
showed that this individual reacted to sulphur dioxide vapour released from the apricots, which 
suggests that the release of sulphur dioxide vapour is an important step in the process leading to an 
asthmatic reaction following ingestion of foodstuffs preserved with sulphiting agents. 
Dose-related respiratory hyper-reactivity has also been documented in a small number of individuals 
following consumption of potassium bisulphite-treated red wine and wine which contained smaller 
amounts of sulphites formed naturally as products of fermentation
12. Although no confirmed case-
reports are available, the possibility· cannot be discounted of asthmatic reactions to other alcoholic-
beverages, such as cider and beer, and to non-alcoholic beverages such as fruit juices, all of which can 
contain sulphiting agents. 
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The aetiology of the asthmatic reaction induced by sulphites present in foodstuffs has not been 
established, but a number of clinical studies in patients have provided evidence that this response 
may be mediated through stimulation of an oro-bronchial reflex by sulphur dioxide vapour released 
from foods, rather than by an immunological mechanism
15. However, the occurrence of rare, 
immunologically-mediated anaphylactic reactions to ingested sulphites has also been reported
3. 
Much of the sulphite in foods is bound in stable or unstable combined forms
2. Further information on 
the relative proportion of free sulphur dioxide in foods and beverages at the point of consumption or 
released from combined forms, and which might potentially form a vapour following consumption 
would be valuable in assessing the relative risks associated with individual foodstuffs. 
4. Discussion 
The Committee reiterates its view that the use of sulphite preservatives in food products poses no 
health hazards to the great majority of people. It is possible that the gastric effects observed in 
animals could also occur in man if there were exposure to high levels of sulphite via the diet, but it 
should be noted that no such gastric reactions in response to levels currently found in food have been 
reported. 
The gastric effects observed in rats, pigs and other species were similar but not identical. The reasons 
for these small species differences are unclear and may in part be due to differences in their anatomy. 
The majority of gastric changes could be described as irritant effects. However, the hyperplasia of 
the chief cells seen in the rat is not consistent with a simple irritant effect and it has been suggested 
that this might be a primary response to sulphites, rather than a reaction to injury, particularly as 
hyperplasia of mucous gland cells, which is common in the recovery of gastric irritancy lesions, was 
not seen in sulphite treated rats
 9. Such lesions could be caused by direct contact of sulphites with the 
chief cells or, possibly but less likely, caused by an indirect mechanism, perhaps by impairment of an 
entero-hormone feedback system'-*. The toxicological significance of these chief cell changes is 
unknown. Despite the observed histopathological differences, there is no difference between rats and 
pigs in the threshold dose level for gastric changes. 
Whilst a number of the gastric changes described above might well be due solely to local direct 
contact with sulphite, it is not possible to rule out an indirect mechanism for some of the effects. This 
indicates that an Acceptable Daily Intake (ADI) should be set based on the no-effect level of 70 mg 
sulphur dioxide/kg bw/day in rats and pigs. In view of the unknown mechanism for the effect on the 
chief cells, and the observation of treatment-related occult blood in the faeces of rats at high doses 
and sporadically at lower doses (including at the no-effect level for stomach effects), there is no 
reason to deviate from the usual safety factor of 100, giving an ADI of 0 - 0.7 mg sulphur dioxide/kg 
bw. This should ensure that gastric reactions will not occur in man. 
However, the Committee is concerned that occasional, severe, asthmatic reactions can occur, even at 
comparatively low levels of exposure. A numerical ADI would not prevent the occurrence of sulphite-
induced asthma; ingestion of any food containing sulphites may be sufficient to trigger a reaction in 
those who are susceptible. The Committee considers that it is appropriate to view this reaction as a 
food intolerance reaction. It is not possible to estimate the number of individuals in the European 
Community that might be susceptible to asthmatic reactions from dietary sulphites with any degree 
of accuracy, as data on the prevalence of asthma in the Community as whole are not available. 
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The estimates of the proportions of asthmatics that may be sensitive to sulphites reported in the 
literature (1-4% of all asthmatics and 5-10% of steroid dependent asthmatics) are probably 
overestimates, since these figures were based on small studies using people referred from allergv 
clinics who had severe asthma and thus were not a random cross-section of the asthmatic or normal 
population
2·
3. 
Nevertheless, the Committee is concerned that there might be in excess of several thousands of 
individuals living in the European Community who are potentially at risk of experiencing asthmatic 
reactions to dietary sulphites. While the actual risk of a severe reaction may be very low, in view of 
the seriousness of the effects reported in some asthmatics and the likelihood that several thousands 
may be at risk of lesser reactions, the Committee considers that the uses of sulphites in food should not 
be greatly extended, even though the ADI might not be exceeded with further added uses. The 
Commission is urged to limit the use of sulphites where possible to those foods in which its 
technological actions are essential, so that the number of sulphite-containing foods asthmatics are 
likely to encounter does not further increase. 
An important safeguard for those who know they are sensitive to sulphites is the facility to consult 
the labels on foods and beverages. The Committee considers that EC labelling regulations should 
ensure that the presence of added sulphite in foods and non-alcoholic beverages is always indicated 
in the list of ingredients. We do not consider that any additional warning about the presence ol 
sulphites is necessary. However, the Committee is concerned that no such labelling is required for 
alcoholic beverages and recommends that the presence of added sulphite should be declared on labels 
of alcoholic beverages. In addition, action should be taken to disseminate information about possible 
reactions to sulphites in foods and beverages to the medical profession anti those suffering from 
asthma. 
5. Recommendations 
The following recommendations were agreed: 
i ) An ADI of 0-0.7 mg sulphur dioxide/kg bw is appropriate. 
ii) Whilst sulphites do not pose a health hazard to the great majority of people, they may pose a 
serious hazard to some people suffering from asthma. The use of sulphites should therefore be 
limited where possible to those foods where there is a sound technological justification for their 
inclusion, in order that the number of sulphite-containing foods asthmatics are likely to 
encounter docs not increase. 
iii) Sensitive individuals should be able to identify the presence of added sulphites in foods and 
non-alcoholic beverages from labelling of ingredients and, if sulphites have been added to foods 
or beverages, they should be listed in the ingredients label irrespective of the final amount 
present. However, alcoholic beverages are currently exempt from such labelling Since some 
wines are known to contain added sulphites or sulphites carried over from their use as 
production/processing aids, the Committee recommends that labelling be extended to include the 
declaration of the presence of sulphites in alcoholic beverages. 
iv) The attention of the medical profession should be brought to the possibility of respiratory 
hyper-reactivity in a small proportion of mainly steroid dependent asthmatics following 
exposure to sulphur dioxide and other sulphiting agents. Sensitive individuals should be made 
aware of the possibility of asthmatic reactions to sulphites in foods and beverages. 
26 Reports of the Scientific Committee for Food (Thirty-fifth series) 25 FEBRUARY 1994 SULPHUR DIOXIDE AND OTHER SULPHITING AGENTS USED AS FOOD PRESERVATIVES 
References 
1. Commission of the European Communities. Food, Science and Techniques. (EUR 7421) Report of 
the Scientific Committee for Food, 11th Series, 47-48, 1981. 
2. Taylor SL, Higley NA and Bush RK. Sulfites in foods: Uses, analytical methods, residues, fate, 
exposure assessment, metabolism, toxicity and hypersensitivity. Advances in Food Research, 30, 
1-64, 1986. 
3. Walker R. Sulphur dioxide and sulphiting agents: Final Report to the Commission of the 
European Communities, DGIII/C-1. 31 March 1992 (unpublished). 
4. Hui JY, Beery JT, Higley NA and Taylor SL. Comparative subchronic oral toxicity of sulphite 
and acetaldehyde hydroxysulphonate in rats. Food and Chemical Toxicology, 27, 349-359, 1989. 
5. Til HP, Feron VJ, De Groot AP and van der Wal P. The toxicity of sulphite II. Short- and long-
term feeding studies in pigs. Food and Cosmetics Toxicology 10, 463- 473,1972. 
6. Til HP, Feron VJ and De Groot ΑΡ. The toxicity of sulphite. Long term feeding and 
multigeneration studies in rats. Food and Cosmetics Toxicology, 10, 291-310,1972. 
7. Feron VJ and Wensvoort P. Gastric lesions in rats after the feeding of sulphite. Path. Europ., 7, 
103-111, 1972. 
8. Feron VJ and Wensvoort P. Gastric and caecal lesions in pigs following the feeding of sulphite. 
Tijdschrift Diergeneeskunde, 98, 377-387, 1973. 
9. Beems RB, Spit, BJ, Koeter HBWM and Feron VJ. Nature and histogenesis of sulphite-induced 
gastric lesions in rats. Experimental and Molecular Pathology, 36, 316-325, 1982. 
10. Til HP and Feron VJ. Toxicology of sulphiting agents I. Animal studies. Food Additives and 
Contaminants, 9, 587-595,1992. 
11. Lafontaine A and Goblet J. The toxicity of sulphites. Archives of the Belgian Medical Society, 
13, 281-287, 1955. 
12. Dahl R, Henriksen JM and Harving H. Red Wine asthma: A controlled challenge study. Journal 
of Allergy Clinical Immunology, 78, (6), 1126-1129, 1986. 
13. Anon. Sulfiting agents: Revocation of GRAS status for use on fresh potatoes served or sold 
unpackaged and unlabelled to consumers. Federal Register 55 (51), 9826-9833, 1990. 
14. Tollefson L., Report on adverse reactions associated with sulfiting agents. US Department of 
Health & Human Services Memorandum. August 16,1991. 
15. Gunnison AF and Jacobson DW. Sulfite hypersensitivity. A critical review. Critical Reviews in 
Toxicology, 17, (3), 185-214, 1987. 
Reports of the Scientific Committee for Food (Thirty-fifth series) 27 OPINION ON BENZOIC ACID AND ITS SALTS 
EXPRESSED ON 25 FEBRUARY 1994 
1. Terms of reference 
To advise on the safety in use of benzoic acid and its salts as food additives. 
2. Introduction 
Benzoic acid and its salts have been extensively used as preservatives in food over many years. The 
Scientific Committee for Food has not previously evaluated or established an ADI for benzoic acid 
and its salts. Benzoic acid and its salts have been previously evaluated in 1974 by the Joint 
FAO/WHO Expert Committee on Food Additives, which established an ADI of 0-5 mg/kg bw, as a 
sum of benzoic acid and its salts (expressed as benzoic acid). 
Benzoic acid occurs naturally in plants, especially fruits and berries, but intakes from natural sources 
are low in comparison with potential intakes from food additive uses. The Committee therefore 
considered it important to evaluate carefully the toxicological information on benzoic acid and its 
salts in relation to their food additive uses. 
3. Summary of metabolism and toxicity data 
Many of the pharmacokinetic observations and toxicological studies on benzoic acid and its salts were 
carried out some years ago and would not fulfil present day criteria. However, there is reasonable 
consistency in the repeat-dose toxicity data and the Committee regards most of the studies as helpful 
for safety evaluation purposes. The more recent studies on benzoate-induced depletion of glycine and 
of glycine metabolism in humans and animals may also explain some of the adverse effects observed in 
earlier studies. 
Benzoate is a normal product of intermediary metabolism of phenylalanine and tyrosine and this 
results in human urinary excretion of a few tens of milligrams of benzoate/kg bw/day. Benzoate 
administered orally to man is rapidly absorbed and excreted in the urine within 14 hours. The main 
metabolite is its glycine conjugate, hippuric acid, with the glucuronyl conjugate and free benzoic acid 
as minor pathways of excretion. The rate limiting step in excretion of hippuric acid is the 
availability of glycine and this accounts for the glycine depletion which can occur when high doses of 
benzoate are administered. For example, in man the bolus dose of sodium benzoate causing 80% 
saturation of the maximal rate of hippuric acid secretion was found to be 28 mg/kg bw (expressed as 
benzoic acid). 
In rats, a single intraperitoneal injection of sodium benzoate, at doses equivalent to 305, 610 or 1220 mg 
benzoic acid/kg bw caused depletion of plasma glycine levels to 50%, 47% and 34% respectively of 
control values. Early sub-chronic studies showed adverse effects on body weight and survival when 
high doses of 1-5% sodium benzoate in the diet were given. Addition of glycine to the diet reduced the 
severity of the body weight loss induced by benzoate administration. 
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An early long-term study in which 1.5% benzoic acid was given in the diet to rats for 18 months 
revealed no adverse effects other than a reduction in food intake and body weight, but was limited in 
scope and did not include histopathological observations. A later life-span carcinogenicity study in 
mice given sodium benzoate in the drinking water at a single dose equivalent to 3.4 g benzoic acid/kg 
bw/day showed an equivocal increase in mammary tumours. A study in rats given 1% or 2% sodium 
benzoate in the diet for 18-24 months, a dose equivalent to 425 or 840 mg benzoic acid/kg bw/day, was 
negative. However, there is some doubt as to whether either of these carcinogenicity studies 
adequately addressed histopathological changes other than neoplastic ones. 
Benzoic acid was negative in gene mutation tests in bacteria (Salmonella typhimurium) and in yeast 
(Saccharomyces cercvisiae), with and without metabolic activation. However it was positive in tests 
for chromosomal aberrations in cultured rat cells in vitro and in a recombination (RFC) assay. It also 
caused cytological effects in Vicia faba root mitotic cells including inhibition of DNA synthesis, 
induction of anaphase bridges and subsequent micronuclei. 
A single teratogenicity study, reported in abstract only, in which sodium benzoate was given 
intraperitoneally up to 1000 mg/kg bw/day on selected days of pregnancy was said to have produced 
adverse effects at the top dose, but was inadequate for evaluation and the route of administration was 
inappropriate for assessment of the effects of dietary benzoate. An early multigeneration study in 
which rats were given the equivalent of 250 or 500 mg benzoic acid/kg bw/day over 4 generations was 
reported to be without effects on growth, fertilitv, lactation or survival. 
In humans, acute toxicity symptoms from high doses are gastro-intestinal irritation, central nervous 
system effects and convulsions. These effects are rapidly reversible and attributable to disturbance of 
acid-base balance. In very early studies bolus doses of 25 mg/kg bw/day for 20 days caused irritation, 
discomfort and malaise, whilst doses up to 14 mg/kg bw/day for 88-92 days were said to be without 
visible effect and doses of 4.3-5.7 mg/kg bw/day for 62 days had no effect on haematology, urine 
composition or nitrogen balance. Glycine deficiency, as detected by measurement of urinary 5-oxo-
proline, accompanied by nausea, bloating and epigastric discomfort, has been observed in humans 
within 2-3 hours of administration of sodium benzoate at doses ranging from 21-135 mg/kg bw 
(expressed as benzoic acid). 
4. Conclusions and recommendations 
The data available give adequate reassurance that the use of benzoic acid and its salts as food 
preservatives is temporarily acceptable. However, the role of glycine in the rate limiting step for 
hippuric acid formation from benzoic acid suggests that there may be a narrow margin between the 
metabolic demand for glycine and the rate at which glycine is formed or made available in the body. 
Glycine is not generally regarded as an essential amino acid but it has been suggested that in rapidly 
growing organisms glycine may be a conditionally essential amino acid and that this fine balance 
might be disturbed by benzoic acid. An adequate teratogenicity study using a dietary route of 
administration is therefore desirable. 
The observations of clastogenic activity of benzoic acid in vitro indicate that it should be tested for 
clastogenic activity in vivo in peripheral lymphocytes or bone marrow in animals and that blood or 
bone marrow levels respectively of benzoic acid should be measured in such a study. 
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An overall no-effect level of 500 mg/kg bw can be taken from the long-term and multigeneration 
studies. The Committee considers that a 100-fold safety factor is appropriate, giving a temporary 
ADI of 0-5 mg/kg bw, as the sum of benzoic acid and its salts, expressed as benzoic acid. This t-ADI is 
below doses causing symptomatic effects in humans. Intolerance to benzoic acid in patients with 
asthma has been recorded but such observations are not relevant to the setting of an ADI. We wish to 
review the situation in 3 years time in the light of any new toxicological studies, along the lines 
suggested above, together with information on consumer intakes of benzoic acid and its salts, which 
we understand will then be available. 
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1. Background 
In its second report on extraction solvents (Scientific Committee for Food, 1992) the Scientific 
Committee for Food had been presented with the results of a 90-day toxicity study on technical 
hexane (light petroleum) with a content of 58% n-hexane (TNO, 1989). In its report the Committee 
was unable to establish whether the no observed effect level (NOEL) of 40 mg/kg bw claimed by the 
study authors was truly a NOEL or a minimal effect level and therefore only gave the substance a 
temporary acceptance. At the same time the Committee recommended that information be sought on 
actual residues occurring in food to allow an evaluation as to whether the maximum residue limits in 
Community legislation remained appropriate and also that the limits should in future be specified in 
terms of n-hexane (the most toxic of the isomers). 
2. Discussion 
The Committee has now had the opportunity to evaluate the original slides from the 90-day toxicity 
study together with an additional analysis by the study authors (TNO, 1992) and is now satisfied 
that 40 mg/kg bw is a true NOEL. 
The extraction solvents directive (EEC, 1988) currently provides for the use of technical hexane in the 
production or fractionation of fats and oils and the production of cocoa butter with a maximum residue 
limit of 5 mg/kg, in the preparation of protein products and defatted flours with a maximum residue 
limit of 10 mg/kg in foods containing them, in the preparation of defatted cereal germs with a 
maximum residue limit of 5 mg/kg, and in the manufacture of defatted soya products with a maximum 
residue limit of 30 mg/kg in the soya product as sold to the consumer. The Committee has been 
informed that for fats and oils, residues of less than 1 mg/kg can now be achieved. With respect to the 
remaining categories of foodstuffs, industry has asked that the existing legal limits be maintained but 
has provided only imprecise information concerning actual residues. 
The latest 90-day study was performed with a technical hexane with an n-hexane content of 58% and 
had a NOEL of 40 mg/kg bw. If it is assumed that the effects seen were due only to n-hexane (which 
has been shown to be the most toxic of the isomers) this would lead to a calculated NOEL for the n-
isomer of 23 mg/kg bw. On the assumption that the maximum content of hexane in any item of food to 
which consumers would be exposed is 30 mg/kg and that such foods might be consumed at a rate of 200 g 
per day (an extreme figure for total daily protein intake), the intake of hexane would equate to 0.1 
mg/kg bw/day for a 60 kg person. Even if all of this hexane consis:ed of the η-isomer, a safety margin 
of around 200 would still exist between the level of exposure and the NOEL. 
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3. Conclusion 
Given that a clear NOEL has now been established and that the present maximum levels as expressed 
in the extraction solvents directive give an adequate margin between the potential exposure and the 
NOEL, the Committee considers the continued use of hexane as an extraction solvent acceptable and 
sees no need from a toxicological point of view to change the limits in the directive. 
The Committee notes that for fats and oils a lower residue limit of 1 mg/kg is now achievable and 
welcomes this development as a contribution to good manufacturing practice. In view of the 
imprecision of the residue data in relation to the other categories of foodstuffs for which hexane is 
permitted as an extraction solvent the Committee recommends that confirmation be sought that in no 
instance will residues exceed 30 mg/kg in products sold to the consumer. 
With a confirmed NOEL and in view of the fact that the toxicity study from which it was derived 
was carried out on technical hexane, the Committee no longer sees a need to express the maximum 
limits as n-hexane as recommended in its second report on solvents. 
The Committee wishes to re-iterate its statement from its first (Scientific Committee for Food, 1981) 
and second reports on solvents that specifications are required to limit the presence of unsaturated 
aliphatic hydrocarbons and polycyclic aromatic hydrocarbons. 
The Committee also wishes to re-iterate its statement from its first report that as ethylmethylketone 
significantly increases the potential for n-hexane to induce neurotic effects and thereby to reduce the 
otherwise adequate safety margin, these substances should not be used together. 
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EXPRESSED ON 23 SEPTEMBER 1994 
1. Terms of reference 
The Committee is asked to advise whether there is any special need on health grounds for maximum 
limits for pesticide residues in relation to foods prepared for infants and young children. 
2. Background 
Limits on residues of pesticides are established at Community level in relation to certain primary 
agricultural products. There are no Community rules setting limits on pesticide residues in processed 
foods. Member States are therefore free to apply national rules, provided they are consistent with 
Member States' obligations under the Treaty of Rome with respect to infra-Community trade. 
With respect to foods specially prepared for infants and young children ("baby foods"), some Member 
States adopt a general, across-the-board policy of requiring such foods to be free from pesticide 
residues. In such cases, the Member States have set limits in their legislation which reflect the limits 
of analytical detection; - i.e. although their legislation provides for certain, very low residues, the 
limits equate to, and are intended to represent, a zero tolerance. Other Member States have adopted a 
policy which provides that, unless other more specific limits apply, pesticide residues may be present 
in baby foods at levels determined by proportional carry over from the pesticides legally present in 
the primary, unprocessed ingredients. 
The question arises, in relation to lindane and to pesticides in general, whether maximum residue 
limits established for foods in general, which take into account the ADI's and are implemented 
through a consideration of carry over, are acceptable and sufficient for foods prepared specially for 
infants and young children; whether specific limits should be set for pesticide residues in baby foods; 
or whether the concept of the ADI is not applicable to infants and young children and cannot therefore 
be used to establish any safe or acceptable level for pesticides in this category of foods. 
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3. Conclusions 
The Committee has previously only considered those pesticides which also can be used as food 
additives. Thus lindane has never been evaluated by SCF. 
The Committee noted, however, that lindane was evaluated on several occasions by JMPR, most 
recently in 1989, when an ADI of 0.008 mg/kg bw was allocated. The substance was evaluated on the 
basis of a wide range of toxicity tests including reproduction studies and studies where very young 
animals were exposed. 
With a residue level of 0.04 mg/kg in baby food for example a child of 10 kg, would have to consume 
2 kg of that food per day, an amount which is physiologically impossible, to reach a dose equalling 
the ADI. The Committee, therefore, has no reason to believe that a content of 0.04 mg lindane/kg baby 
food would cause reason for concern. 
The Committee is presently reviewing the scientific basis for establishing ADI's in general and their 
applicability to infants and young children. The Committee intends to issue a report on this matter 
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(MODIFIED CELLULOSE GUM) 
EXPRESSED ON 23 SEPTEMBER 1994 
1. Terms of reference 
The Committee was asked to consider the safety-in-use of the modified cellulose gum, cross-linked 
sodium carboxymethylcellulose (also known as Croscarmellose) as a disintegrant in sweetener tablets. 
2. Discussion 
The substance requested is an internally cross-linked form of the currently permitted food additive, 
sodium carboxymethylcellulose (E466). In considering the submission, the Committee took into account 
not only the toxicological data available on the substance itself but also that available on the 
"parent" gum, sodium carboxymethylcellulose. The parent substance, sodium carboxymethylcellulose 
is of low toxicity and has a long history of safe use. It is only poorly absorbed in man and laboratory 
animals and shows little degradation in the gastrointestinal tract. When sodium carboxymethyl-
cellulose is modified to form Croscarmellose, the cross-linking makes it less soluble in water and in 
simulated gastric and intestinal environments than the parent substance. It is even less likely to be 
absorbed and degraded than the parent substance. 
The available toxicity data on Croscarmellose itself include acute oral toxicity studies in rats and 
mice, a 13-week oral feeding study in rats, and a gene mutation study in bacteria. None of these 
indicated any significant toxic effects. The only effects observed (reduced body weight gain, reduced 
efficiency of food utilisation and intermittent incidence of soft, moist faeces) were caracteristic for 
rodents fed high amounts of non-nutritious, non-absorbed, high molecular weight materials. Similar 
effects were seen in animals given the parent substance, sodium carboxymethylcellulose, at similar 
doses. 
It can be estimated that consumption of Croscarmellose would be no more than around 1 mg/kg bw/day 
for a 60 kg person using 12 sweetener tablets per day, each tablet weighing 90 mg and containing 6% 
Croscarmellose. It can be further estimated from the solubility data for Croscarmellose in simulated 
gastrointestinal fluids that a maximum of 0.05 mg/kg bw/day would be available for absorption. 
The Committee was also provided with a specification and details of the method of production of 
Croscarmellose, including information on the identity of the reagents used for production and their 
residues in the finished product. The Committee was satisfied that these gave no cause for concern. 
3. Conclusion 
The extent of the toxicological data available is insufficient to establish an ADI but in the light of 
the limited intake that would result, the Committee agreed that sodium carboxymethylcellulose, 
cross-linked, is acceptable for use as a disintegrant for sweetener tablets. 
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EXPRESSED ON 23 SEPTEMBER 1994 
1. Terms of reference 
The Committee was asked to review two dossiers on invertase. The dossiers were presented as required 
in the SCF "Guidelines for the presentation of data on food enzymes" (27th Report Series) and 
contained information on the enzyme, the source material, manufacturing process and purification 
methods. The enzyme is prepared by good manufacturing practice and is being tested for content of 
contaminants. 
2. Conclusion 
The enzyme preparations concerned are derived from Saccharomyces cerevisiae. On the grounds that 
the source organism has a long history of safe food use and, by virtue of this fact is considered to be 
acceptable by the Committee in its Guidelines, the Committee agreed that invertase preparations 
derived from Saccharomyces cerevisiae are acceptable for food use. Members stressed that while this 
acceptance applies to all invertase preparations from Saccharomyces cerevisiae, it is subject to the 
commercial product being in compliance with the general requirements and specifications set out in the 
Committee's Guidelines (27th Series of Reports, pages 18-19) and the fact that the source organism 
has not been subjected to any recombinant genetic engineering (i.e. is not one in which the genetic 
material has been altered in a way that does not occur naturally by mating and/or natural 
recombination). 
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EXPRESSED ON 23 SEPTEMBER 1994 
1. Terms of reference 
The Committee is asked to make a preliminary evaluation of risk to public health resulting from 
dietary exposure to the following contaminants: 
- Aflatoxins Bi, B2, Gj and G2 
- Ochratoxin A 
- Patulin 
2. Background 
In the light of moves in some Member States to introduce national limits for certain mycotoxins in food, 
the Committee was asked to carryout an urgent evaluation of the status of the recommendations of 
international bodies concerning the toxicology of these substances. In particular, the Committee was 
requested to advise the Commission on the possibility of using for Community purposes, possibly on a 
provisional basis, the tolerable intakes or other recommendations established by JECFA or other 
international organisations. 
The urgency of the question did not permit the Committee to estimate dietary exposure to these 
mycotoxins which will be addressed at a later stage. 
During the course of the evaluation, the Committee also reviewed recommendations of international 
organisations in relation to aflatoxin Mi. The conclusions for this substance are included under the 
section dealing with aflatoxins for the sake of completeness. 
3. Conclusions 
Aflatoxins Bj, Bz, Gì and G2 
Aflatoxins are produced by three Aspergillus species, i.e. A. flavus, A. parasiticus and the rare 
species A. nomius. It is generally considered that A. flavus produces aflatoxins Bi and B2, whereas A. 
parasiticus produces aflatoxins Bj, B2, G¡ and G2. 
The aflatoxin producing Aspergillus species, and consequently dietary aflatoxins contamination, are 
ubiquitous in areas of the world with hot, humid climates. Since countries in colder climatic areas 
import food from areas where aflatoxin levels are high, however, aflatoxins are of world-wide 
concern. Aflatoxins are frequent contaminants of corn, peanuts, dried figs, brazil nuts and other 
agricultural products from subtropic and tropic areas. There are many surveys on the occurrence of 
aflatoxins in foods and feeds. 
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Aflatoxin Bi is the most frequent type present in contaminated samples (60-80% of the total aflatoxin 
content) and aflatoxins B2, G] and Gi are generally not reported in the absence of aflatoxin B]. 
Aflatoxins B2 and G2 are typically present in much lower quantities. Depending on the method of 
analysis, the detection limit is 0.01 - 10 μg/kg. The limits of detection of routine methods used 
internationally are in the range of 5 - 10 μg/kg. 
Intake of a large quantity (milligrams) of aflatoxins has a number of toxic effects (primarily an acute 
toxic effect in the liver) and intake of large or smaller quantities has a carcinogenic effect on the 
liver. 
Very extensive assessments of the toxic effects of these substances have been carried out among others 
by the World Health Organisation (WHO) (1987), Danish report (1989), Kuiper and Goodman (1991), 
International Agency for Research on Cancer (IARC) (1993). 
The potential carcinogenicity of aflatoxins has been examined in a large number of population studies, 
both cohort and correlation studies. Most of them were carried out in Africa and Asia, where 
substantial quantities of aflatoxins occur in basic foodstuffs. It can be concluded that there is good 
accordance between the results of practically all the existing population studies, even though these 
have been carried out in population groups where other known risk factors for liver cancer such as 
hepatitis B-virus and alcohol, vary considerably. IARC concluded in 1993 that there is sufficient 
evidence in humans for the carcinogenicity of naturally occurring mixtures of aflatoxins, and for the 
carcinogenicity of aflatoxin B]. The overall evaluation of IARC was: "Naturally occurring aflatoxins 
are carcinogenic to humans (Group 1)". 
Aflatoxins are extremely potent carcinogens in animal experiments and they are potent in all animal 
species investigated, i.e. mice, rats, hamsters, fish, duck, tree shrews and monkeys, and in several 
organs, the liver being the primary target. 
A linear dose-response relationship has been demonstrated for aflatoxin B) in at least two animal 
species down to doses of less than 0.1 Ug/kg b.w./day. Although aflatoxin G\ has been tested less 
extensively, it appeared to be toxicologically similar to aflatoxin Bi. It is a slightly less potent liver 
carcinogen, with a comparable carcinogenic potency to aflatoxin B], i.e. within a factor of 10. 
Much less data are available describing the toxic/carcinogenic potential of aflatoxin B2 and aflatoxin 
G2. 
IARC concluded in 1993 that there is sufficient evidence in experimental animals for the 
carcinogenicity of naturally occurring mixtures of aflatoxins and aflatoxin B] and Gi; in experimental 
animals there is limited evidence for carcinogenicity of aflatoxin B2 and inadequate evidence for the 
carcinogenicity of aflatoxin C>2-
Aflatoxins, especially Bi, have been tested extensiveley for genotoxicity. Aflatoxin B] is consistently 
found to be genotoxic, producing adducts in humans and animals in vivo and chromosomal anomalies in 
rodents and, in a single study, in rhesus monkeys in vivo. It induces DNA damage, gene mutation, 
chromosomal anomalies and cell transformation in mammalian cells in vitro, in insects, lower 
eukaryotes and bacteria. Fewer studies have been performed, in descending order, with aflatoxins B2, 
Gi and G2 but these showed a comparable genotoxic profile. 
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Aflatoxins are genotoxic carcinogens. For this type of carcinogen, it is generally felt that there is no 
threshold dose below which no tumour formation would occur. In other words, only a zero level of 
exposure will result in no risk. 
Several mathematical and biological models have been used by different organisations to 
approximate the risk of tumour formation at low levels of aflatoxin exposure, based on human and 
animal data primarily for aflatoxin Bj. It should be noted that the decision as to which risk level is 
judged to be acceptable or tolerable is socio-political and goes beyond scientific assessment. 
Similarity in the toxicological profile of aflatoxins Bi, B2, Gj and G2, despite a restricted data base 
for the latter three and especially aflatoxins B2 and G 2, justifies a risk assessment for all these 
aflatoxins as a group, based on the data of aflatoxin Bi. This group approach is moreover supported by 
the fact that aflatoxins G^ B2, and G2 are generally not detected in the absence of aflatoxin Bi and, if 
present, occur at lower quantities in the food. 
In summary, based on the vast amount of data and recent evaluations on aflatoxins, the Committee 
agreed that there was no need for it to do further work in the area of toxicological assessment. It 
agreed with the recent evaluations of IARC (1993) with respect to the carcinogenicity and 
genotoxicity of the aflatoxins. From the many reports on risk assessment, it can be concluded that even 
very low levels of exposure to aflatoxins, i.e. 1 ng/kg b.w./day or less still contribute to the risk of 
liver cancer. 
Aflatoxin M, 
Aflatoxin M] is a metabolic hydroxylation product of aflatoxin Bi. It can occur in the absence of the 
other aflatoxins. Human exposure occurs primarily via milk and milk products from animals that 
have consumed contaminated feed; it has also been found in human milk samples. 
Aflatoxin M] produced DNA damage in rodent cells in vitro and gene mutation in bacteria. With 
respect to the carcinogenicity of aflatoxin Mi, IARC (1993) concluded that there is madequate 
evidence in humans, but sufficient evidence in experimental animals (liver tumours). The overall 
evaluation of IARC was: "Aflatoxin Mi is possibly carcinogenic to humans (Group 2B)". 
The Committee concluded that there is sufficient evidence that aflatoxin Mi is a genotoxic carcinogen; 
its carcinogenic potency is estimated to be approximately 10 times lower than aflatoxin Bi. 
Patulin 
Patulin is a mycotoxin produced by fungi belonging to several genera, including Pénicillium, 
Aspergillus and Byssochlamys species. Although patulin can occur in many mouldy fruits, grains and 
other foods, the major sources of patulin contamination are apples and apple products. 
Patulin is characterised by its strong affinity for sulphhydryl groups. Patulin adducts formed with, 
for example, cysteine in the diet are less toxic than the unmodified compound in acute toxicity studies, 
teratogenicity and mutagenicity studies. The affinity of patulin for sulphhydryl groups explains its 
inhibitory activity on many enzymes. 
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As patulin adducts are formed in the diet and the major exposure of humans to patulin is via fruit 
drinks such as apple juice and apple cider, the most relevant studies to consider for toxicological 
evaluation are those in which patulin was administered in solution by gavage or dissolved in 
drinking water. 
In acute and short-term studies, patulin caused gastrointestinal hyperaemia, distension, 
haemorrhage and ulceration. In long-term studies (at lower dose levels) these effects were not 
observed. Short-term in vitro studies revealed that patulin is not mutagenic, but that it has 
clastogenic activity in some test systems. No clear teratogenic effects were published. In a combined 
reproduction/long-term/carcinogenicity studies in rats and in long-term studies in mice and rats no 
carcinogenic properties were established (JECFA, 1988). Based on these combined reproduction /long-
term/carcinogenicity studies, JECFA allocated a Provisional Tolerable Weekly Intake (PTWI) of 7 
μg/kg b.w. (JECFA, 1988). The JECFA review did not include the results of a subchronic study in rats 
with patulin administered through drinking water in which the most sensitive effect was 
impairment of the kidney function (decreased creatinine clearance) and hyperaemia in the duodenum. 
The no observed adverse effect level in this study was 0.8 mg/kg b.w. In the same study, a different 
response was found in conventional and in specific pathogen free laboratory animals based on the 
antibiotic effect of patulin in gut micro flora, leading to mortality at a much lower dose level in 
conventional animals (Speijers et al. 1988). 
IARC (1986) concluded that no evaluation could be made of the carcinogenicity of patulin to humans 
and that there is inadequate evidence in experimental animals. The overall evaluation of IARC 
(1987) was: "Patulin is not classifiable as to its carcinogenicity to humans (Group 3)". 
The Committee agrees for the time being with the JECFA and IARC conclusions. It proposes to 
reconsider its opinion in the light of new information. 
Ochratoxin A 
Ochratoxin A is a mycotoxin produced by several fungi (Pénicillium and Aspergillus species), and 
occurs naturally in a variety of plant products such as cereals, cereal products, coffee beans, beans and 
pulses all over the world. It occurs also by transfer from feed in animal products especially in organ 
meat (kidney, liver, blood) and it is even detected in human blood. 
Ochratoxin A causes a number of toxic effects in laboratory animals, primarily of a teratogenic, 
immunological, nephrotoxic and carcinogenic (mainly urinary tract tumours) nature. The most 
sensitive and notable effects are the nephrotoxicity and the kidney tumours (Dirheimer and Creppy, 
1991). According to IARC (1993), there is sufficient evidence in animals for carcinogenicity of 
ochratoxin A and inadequate evidence in humans for carcinogenicity. The overall evaluation of IARC 
was: "Ochratoxin A is possibly carcinogenic to humans (Group 2B)". Ochratoxin A does not induce 
mutations in in vitro systems, but it induces DNA-damage in rodent cells in vitro and in rodents in 
vivo. A rat hepatocyte culture medium mediated mutagenic response was demonstrated in S. 
typhimunum. Ochratoxin A also formed DNA-adducts in mouse kidney and to a lesser extent in liver 
and spleen (IARC 1993). 
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Ochratoxin A has also been associated with the nephropathy in humans from the Balkan area 
(Balkan Endemic Nephropathy - BEN), and with the occurrence of kidney tumours (Ceovic et al. 
1992). JECFA (1991) concluded that the epidemiological data on BEN and kidney tumours were not 
conclusive with respect to the role of ochratoxin A since other factors might also be involved. 
Ochratoxin A was evaluated by Kuiper-Goodman (1989), by JECFA (1991), and by the Nordic Working 
Group on Food Toxicology and Risk Evaluation (1991). 
JECFA (1991) has based a provisional tolerable weekly intake value on the lowest observed effect 
level (0.008 mg ochratoxin A/kg b.w.) for kidney damage in pigs (the most sensitive species) and a 
500-fold margin of safety. The PTWI was allocated at 112 ng/kg b.w./week (16 ng/kg b.w./day). The 
Kuiper-Goodman review and the report of the Nordic Group regard the carcinogenic property as the 
most important. The Nordic Working Group has estimated an acceptable safe level for ochratoxin A 
at 5 ng/kg b.w./day based on a lifetime risk level of 1:10
6. Kuiper-Goodman estimated a safe level for 
ochratoxin A at 0.2 ng/kg b.w./day at the same risk level. 
The Committee agrees that ochratoxin A is a potent nephrotoxic agent, a carcinogen and that it has 
genotoxic properties. The genotoxic effect may also be explained by an indirect mechanism involving 
impaired protein synthesis. 
The Committee concluded that although the risk assessments are on different toxicological end points 
there was a broad agreement between the calculated values (16, 5 and 0.2 ng/kg b.w./day) and 
provisionally supports the conclusion that an acceptable safe level of daily exposure would fall in the 
range of a few ng/kg b.w./day. 
The Committee proposes to reconsider its opinion in the light of new information. 
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